Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Clinical Trials and Medical Trials is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.

Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.

Register as a Clinical Trial volunteer.

View information about current Clinical Trials.

If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.

Clinical research companies often offer financial compensation for your time and expenses.

Clinical Trial Information

Register now for clinical trials


53 Ebola-blocking drugs identified among existing medications

Using high-speed screening technology, researchers have identified 53 drugs – including some antihistamines and antidepressants – that may prevent Ebola from entering human cells. Go to Source

more >

Herceptin for HER2-positive breast cancer improves long-term survival

A new study shows that when added to chemotherapy, trastuzumab – commonly known as Herceptin – significantly improves long-term survival of HER2-positive breast cancer patients. Go to Source

more >

VR475 shown significant benefit in a Phase IIb/III trial for severe asthma

Vectura Group plc has announced the publication in the European Respiratory Journal (ERJ) of a clinical study demonstrating positive results from its Phase IIb/III (Acti-AICS-001) clinical trial… Go to Source

more >

Tamoxifen has reduced breast cancer rates ‘by a third’

A well-established and effective treatment for breast cancer, tamoxifen has now been shown to have long-term preventive benefits for women at high risk. Go to Source

more >

Primary data from Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy announced

UCB has announced the primary efficacy and safety data from the latest Phase 3 study evaluating brivaracetam (fixed doses of 100 and 200 mg/day with no up-titration) as adjunctive treatment in… Go to Source

more >

Follow-up data from idelalisib (Zydelig) registrational studies in patients with chronic lymphocytic leukaemia and follicular lympho

Gilead Sciences, Inc. has announced long-term follow-up results from the registration studies further describing the duration of response, progression-free survival (PFS) and the safety profile for… Go to Source

more >